Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease

Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common global chronic liver disease. Jiuzhuan Huangjing Pills (JHP) have been used for the treatment of human disease for over a thousand years, but their efficacy and underlying mechanism(s) of action against MAFLD are un...

Full description

Bibliographic Details
Main Authors: Jian-Kang Mu, Lei Zi, Yan-Qin Li, Li-Ping Yu, Zheng-Guo Cui, Ting-Ting Shi, Fan Zhang, Wen Gu, Jun-Jie Hao, Jie Yu, Xing-Xin Yang
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221008751